The End of Dieting: How to Live for Life (42 page)

55
.  Galleano M, Pechanova O, Fraga CG. Hypertension, nitric oxide, oxidants, and dietary plant polyphenols.
Curr Pharm Biotechnol
. 2010;11:837–848. Basu A, Rhone M, Lyons TJ. Berries: emerging impact on cardiovascular health.
Nutr Rev
. 2010;68:168–177. Chong MF, Macdonald R, Lovegrove JA. Fruit polyphenols and CVD risk: a review of human intervention studies.
Brit J Nutr
. 2010;104(suppl 3):S28–S39. Basu A, Du M, Leyva MJ, et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome.
J Nutr
. 2010;140:1582–1587.

56
.  Devore EE, Kang JH, Breteler MM, et al. Dietary intakes of berries and flavonoids in relation to cognitive decline.
Ann Neurol
. 2012;72(1):135–143.

57
.  Joseph JA, Shukitt-Hale B, Willis LM. Grape juice, berries, and walnuts affect brain aging and behavior.
J Nutr
. 2009;139:1813S–1817S. Ma Y, Njike VY, Millet J, et al. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial.
Diabetes Care
. 2010;33:227–232.

58
.  Mattes RD, Dreher ML. Nuts and healthy body weight maintenance mechanisms.
Asia Pac J Clin Nutr
. 2010;19:137–141.

59
.  Thompson LU, Chen JM, Li T, et al. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer.
Clin Cancer Res
. 2005; 11:3828–3835.

60
.  McCann SE, Thompson LU, Nie J, et al. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res Treat
. 2010;122(1):229–235.

61
.  Connor WE. Importance of n-3 fatty acids in health and disease.
Am J Clin Nutr
. 2000;71(suppl 1):171S–175S.

62
.  Yehuda S, Rabinovitz S, Mostofsky DI. Mixture of essential fatty acids lowers test anxiety.
Nutr Neurosci
. 2005;8(4):265–267. Lucas M, Mirzaei F, O’Reilly EJ, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study.
Am J Clin Nutr
. 2011;93(6):1337–1343.

63
.  Shardell MD, Alley DE, Hicks GE, et al. Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey.
Nutr Res
. 2011;31:178–189.

64
.  Canene-Adams K, Campbell JK, Zaripheh S, et al. The tomato as a functional food.
J Nutr
. 2005;135:1226–1230.

65
.  Van Breemen RB, Pajkovic N. Multitargeted therapy of cancer by lycopene.
Cancer Lett
. 2008;269:339–351.

66
.  Rizwan M, Rodriquez-Blanco I, Harbottle A, et al. Tomato paste rich in lycopene protects against cutaneous photodamage in humans in vivo.
Br J Dermatol
. 2011;164(1):154–162.

67
.  Rissanen TH, Voutilainen S, Nyyssönen K, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Br J Nutr
. 2001;85:749–754. Rissanen T, Voutilainen S, Nyyssönen K, et al. Lycopene, atherosclerosis, and coronary heart disease.
Exp Biol Med
. 2002;227:900–907. Rissanen TH, Voutilainen S, Nyyssönen K, et al. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Am J Clin Nutr
. 2003;77:133–138.

68
.  Sesso HD, Buring JE, Norkus EP, et al. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women.
Am J Clin Nutr
. 2004;79:47–53.

69
.  Hak AE, Ma J, Powell CB, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke.
Stroke
. 2004;35:1584–1588.

70
.  Karppi J, Laukkanen JA, Sivenius J, et al. Serum lycopene decreases the risk of stroke in men: a population-based follow-up study.
Neurology
. 2012;79:1540–1547.

71
.  Karppi J, Laukkanen JA, Makikallio TH, et al. Low serum lycopene and beta-carotene increase risk of acute myocardial infarction in men.
Eur J Public Health
. 2012;22(6):835–840.

72
.  Silaste ML, Alfthan G, Aro A, et al. Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation.
Br J Nutr
. 2007;98:1251– 1258. Burton-Freeman B, Talbot J, Park E, et al. Protective activity of processed tomato products on postprandial oxidation and inflammation: a clinical trial in healthy weight men and women.
Mol Nutr Food Res
. 2012;56:622–631. Hadley CW, Clinton SK, Schwartz SJ. The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage.
J Nutr
. 2003;133:727–732.

73
.  Xaplanteris P, Vlachopoulos C, Pietri P, et al. Tomato paste supplementation improves endothelial dynamics and reduces plasma total oxidative status in healthy subjects.
Nutr Res
. 2012;32:390–394.

74
.  Ried K, Fakler P. Protective effect of lycopene on serum cholesterol and blood pressure: meta-analyses of intervention trials.
Maturitas
. 2011;68:299–310.

75
.  Palozza P, Parrone N, Catalano A, et al. Tomato lycopene and inflammatory cascade: basic interactions and clinical implications.
Curr Med Chem
. 2010;17:2547–2563. Palozza P, Parrone N, Simone RE, et al. Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies.
Arch Biochem Biophys
. 2010;504:26–33.

76
.  USDA, Economic Research Service. Food availability (per capita) data system. http://www.ers.usda.gov/data-products/food-availability-(per-capita)-data-system.aspx.

77
.  Brown MJ, Ferruzzi MG, Nguyen ML, et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection.
Am J Clin Nutr
. 2004;80:396–403.

78
.  Van het Hof KH, de Boer BC, Tijburg LB, et al. Carotenoid bioavailability in humans from tomatoes processed in different ways determined from the carotenoid response in the triglyceride-rich lipoprotein fraction of plasma after a single consumption and in plasma after four days of consumption.
J Nutr
. 2000;130:1189–1196. Goltz SR, Campbell WW, Chitchumroonchokchai C, et al. Meal triacylglycerol profile modulates postprandial absorption of carotenoids in humans.
Mol Nutr Food Res
. 2012;56:866–877.

Chapter Five: Nutritarian Boot Camp

1
.  USDA, Economic Research Service. Food availability (per capita) data system. http://www.ers.usda.gov/data-products/food-availability-(per-capita)-data-system.aspx#.Ud8A6UG1GCk. Lin B-H, Yen ST. The U.S. grain consumption landscape: who eats grain, in what form, where, and how much. USDA Economic Research Service; Economic Research Report No. 50; November 2007; http://www.ers.usda.gov/media/216648/err50_1_.pdf.

2
.  Halton TL, Willett WC, Liu S, et al. Potato and french fry consumption and risk of type 2 diabetes in women.
Am J Clin Nutr
. 2006;83(2):284–290.

3
.  Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P. Glycemic index, glycemic load, and cancer risk: a meta-analysis.
Am J Clin Nutr
. 2008;87(6):1793– 1801. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies.
Am J Clin Nutr
. 2008;87(3):627–637.

4
.  Williams CD, Satia JA, Adair LS, et al. Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans.
Cancer Epidemiol Biomarkers Prev
. 2009;18(5):1552–1561.

5
.  Sieri S, Krogh V, Berrino F, et al. Dietary glycemic load and index and risk of coronary heart disease in a large Italian cohort: the EPICOR study.
Arch Intern Med
. 2010;170(7):640–647.

6
.  Burger KNJ, Beulens JWJ, Boer JMA, et al. Dietary Glycemic Load and Glycemic Index and Risk of Coronary Heart Disease and Stroke in Dutch Men and Women: The EPIC-MORGEN Study.
PLoS One
. 2011;6(10):e25955.

7
.  Holt S, Brand-Miller J, Petocz P. An insulin index of foods: the insulin demand generated by 1000-Kj portions of common foods.
Am J Clin Nutr
. 1997;66:1264–1276. Bao J, de Jong V, Atkinson F, et al. Food insulin index: physiologic basis for predicting insulin demand evoked by composite meals.
Am J Clin Nutr
. 2009;90:986–992.

8
.  Vergnaud AC, Norat T, Romaguera D, et al. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study 1,2,3.
Am J Clin Nutr
. 2010;92(2):398–407. Sabaté J, Ang Y. Nuts and health outcomes: new epidemiologic evidence.
Am J Clin Nutr
. 2009;89(5):1643S–1648S. Fraser GE, Sabaté J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study.
Arch Intern Med
. 1992;152(7):1416–1424. Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies.
Br J Nutr
. 2006;96(suppl 2):S68–78. Sabaté J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials.
Arch Intern Med
. 2010;170(9):821–827. Mattes RD, Kris-Etherton PM, Foster GD. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults.
J Nutr
. 2008;138:1741S–1745S. Bes-Rastrollo M, Sabaté J, Gómez-Gracia E, et al. Nut consumption and weight gain in a Mediterranean cohort: the SUN study.
Obesity
. 2007;15:107–116. Bes-Rastrollo M, Wedick NM, Martínez-González MA, et al. Prospective study of nut consumption, long-term weight change, and obesity risk in women.
Am J Clin Nutr
. 2009;89:1913–1919.

9
.  Chitnis MM, Yuen JS, Protheroe AS, et al. The type 1 insulin-like growth factor receptor pathway.
Clin Cancer Res
. 2008;14:6364–6370. Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene.
Arch Physiol Biochem
. 2009;115:58–71. Davies M, Gupta S, Goldspink G, et al. The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.
Int J Colorectal Dis
. 2006;21:201–208. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.
J Natl Cancer Inst
. 2002;94:972–980. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.
Int J Cancer
. 2009;124(10):2416–2429.

10
.  Werner H, Bruchim I. The insulin-like growth factor-1 receptor as an oncogene.
Arch Physiol Biochem
. 2009;115(2):58–71. Chitnis MM, Yuen JS, Protheroe AS, et al. The type 1 insulin-like growth factor receptor pathway.
Clin Cancer Res
. 2008;14(20):6364–6370.